BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 19891232)

  • 1. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
    Shema L; Ore L; Geron R; Kristal B
    Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-acquired acute kidney injury in Israel.
    Shema L; Ore L; Geron R; Kristal B
    Isr Med Assoc J; 2009 May; 11(5):269-74. PubMed ID: 19637503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and renal consequences of contrast-induced nephropathy.
    Finn WF
    Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    McCullough P
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of contrast-induced nephropathy.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
    Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped?
    Kulvatunyou N; Rhee PM; Carter SN; Roberts PM; Lees JS; Bender JS; Albrecht RM
    Am Surg; 2011 Jun; 77(6):686-9. PubMed ID: 21679633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
    Reddan D; Fishman EK
    Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast nephropathy and its prevention].
    Skulec R; Bĕlohlávek J; Kovárník T; Linhart A; Aschermann M
    Vnitr Lek; 2003 Feb; 49(2):127-33. PubMed ID: 12728580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-induced nephropathy: what are the true clinical consequences?
    Rudnick M; Feldman H
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):263-72. PubMed ID: 18178787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M; Al-Bitar S; Al-Deen Zaiat K
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for contrast-induced nephropathy in elderly trauma patients.
    Finigan R; Pham J; Mendoza R; Lekawa M; Dolich M; Kong A; Bernal N; Lush S; Barrios C
    Am Surg; 2012 Oct; 78(10):1114-7. PubMed ID: 23025953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome.
    Lakhal K; Ehrmann S; Chaari A; Laissy JP; Régnier B; Wolff M; Pajot O
    J Crit Care; 2011 Dec; 26(6):593-9. PubMed ID: 21737245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.